Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome

International Journal of Hematology

Volumn 89, Issue 2, 2009, Pages 173-187

  Prall, Wolf C ^a,e   Czibere, Akos ^a,b   Grall, Franck ^b   Spentzos, Dimitrios ^b   Steidl, Ulrich ^c   Giagounidis, Aristoteles Achilles Nikolaus ^d   Kuendgen, Andrea ^a   Otu, Hasan ^b   Rong, Astrid ^a   Libermann, Towia A ^b   Germing, Ulrich ^a   Gattermann, Norbert ^a   Haas, Rainer ^a   Aivado, Manuel ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d ST JOHANNES HOSPITAL   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

cDNA array; Gene expression; IEX 1; MDS; Survival

Indexed keywords

COMPLEMENTARY DNA; PROTEASOME; RNA;

ADULT; AGED; ARTICLE; BONE MARROW; CD34 SELECTION; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; SURVIVAL TIME; UNINDEXED SEQUENCE; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; APOPTOSIS REGULATORY PROTEINS; BONE MARROW CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; SURVIVAL RATE; YOUNG ADULT;

EID: 67349236630     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0242-9     Document Type: Article

References (61)

1. HP Koeffler DW Golde 1978 Cellular maturation in human preleukemia Blood 52 355 61
2. A Raza S Alvi RZ Borok 1997 Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationship Leuk Lymphoma 27 111 8
3. U Germing B Hildebrandt M Pfeilstocker 2005 Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS) Leukemia 19 2223 31 10.1038/sj.leu.2403963
4. M Nyakern PL Tazzari C Finelli 2006 Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients Leukemia 20 230 8 10.1038/sj.leu.2404057
5. H Niimi H Harada Y Harada 2006 Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations Leukemia 20 635 44 10.1038/sj.leu.2404136
6. M Okamoto T Shichishima H Noji 2006 High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome Leukemia 20 627 34 10.1038/sj.leu.2404135
7. W Ingram NC Lea J Cervera 2006 The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow Leukemia 20 1319 21 10.1038/sj.leu.2404215
8. MK Magnusson KE Meade R Nakamura J Barrett CE Dunbar 2002 Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene Blood 100 1088 91 10.1182/blood-2002-01-0165
9. WC Prall A Czibere M Jager 2007 Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cells Mech Ageing Dev 128 503 10 10.1016/j.mad.2007.06.008
10. U Steidl R Kronenwett UP Rohr 2002 Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells Blood 99 2037 44 10.1182/blood.V99.6.2037
11. M Herrler 2000 Use of SMART-generated cDNA for differential gene expression studies J Mol Med 78 B23
12. U Steidl S Bork S Schaub 2004 Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators Blood 104 81 8 10.1182/blood-2004-01-0373
13. HL Kang S Benzer KT Min 2002 Life extension in Drosophila by feeding a drug Proc Natl Acad Sci USA 99 838 43 10.1073/pnas.022631999
14. O Modlich HB Prisack M Munnes W Audretsch H Bojar 2004 Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease Clin Cancer Res 10 6418 31 10.1158/1078-0432.CCR-04-1031
15. M Prosniak DC Hooper B Dietzschold H Koprowski 2001 Effect of rabies virus infection on gene expression in mouse brain Proc Natl Acad Sci USA 98 2758 63 10.1073/pnas.051630298
16. H Huang S Colella M Kurrer Y Yonekawa P Kleihues H Ohgaki 2000 Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays Cancer Res 60 6868 74
17. T Beissbarth K Fellenberg B Brors 2000 Processing and quality control of DNA array hybridization data Bioinformatics 16 1014 22 10.1093/bioinformatics/ 16.11.1014
18. J Quackenbush 2001 Computational analysis of microarray data Nat Rev Genet 2 418 27 10.1038/35076576
19. SA Armstrong JE Staunton LB Silverman 2002 MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Nat Genet 30 41 7 10.1038/ng765
20. TR Golub DK Slonim P Tamayo 1999 Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 531 7 10.1126/science.286.5439.531
21. D Spentzos DA Levine MF Ramoni 2004 Gene expression signature with independent prognostic significance in epithelial ovarian cancer J Clin Oncol 22 4700 10 10.1200/JCO.2004.04.070
22. B Wu T Abbott D Fishman 2003 Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data Bioinformatics 19 1636 43 10.1093/bioinformatics/btg210
23. C Li WH Wong 2001 Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection Proc Natl Acad Sci USA 98 31 6 10.1073/pnas.011404098
24. G Chen W Zeng A Miyazato 2004 Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities Blood 104 4210 18 10.1182/blood-2004-01-0103
25. WK Hofmann S de Vos M Komor D Hoelzer W Wachsman HP Koeffler 2002 Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow Blood 100 3553 60 10.1182/blood.V100.10.3553
26. H Mano 2006 DNA micro-array analysis of myelodysplastic syndrome Leuk Lymphoma 47 9 14 10.1080/10428190500264231
27. A Miyazato S Ueno K Ohmine 2001 Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction Blood 98 422 7 10.1182/blood.V98.2.422
28. A Pradhan A Mijovic K Mills 2004 Differentially expressed genes in adult familial myelodysplastic syndromes Leukemia 18 449 59 10.1038/sj.leu.2403265
29. M Ueda J Ota Y Yamashita 2003 DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome Br J Haematol 123 288 96 10.1046/j.1365-2141.2003.04601.x
30. A Pellagatti N Esoof F Watkins 2004 Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology Br J Haematol 125 576 83 10.1111/j.1365-2141.2004.04958.x
31. A Pellagatti C Fidler JS Wainscoat J Boultwood 2005 Gene expression profiling in the myelodysplastic syndromes Hematology 10 281 7 10.1080/10245330500065680
32. DP Steensma A Tefferi 2003 The myelodysplastic syndrome(s): a perspective and review highlighting current controversies Leuk Res 27 95 120 10.1016/S0145-2126(02)00098-X
33. K Allampallam V Shetty S Hussaini 1999 Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes Anticancer Res 19 5323 8
34. J Holmes C Wareing A Jacobs JD Hayes RA Padua CR Wolf 1990 Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data Br J Cancer 62 209 12
35. C Ries F Loher C Zang MG Ismair PE Petrides 1999 Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes Clin Cancer Res 5 1115 24
36. JC Gasson DW Golde SE Kaufman 1985 Molecular characterization and expression of the gene encoding human erythroid-potentiating activity Nature 315 768 71 10.1038/315768a0
37. L Guedez WG Stetler-Stevenson L Wolff 1998 In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 J Clin Invest 102 2002 10 10.1172/JCI2881
38. J Chen T Willingham LR Margraf N Schreiber-Agus RA DePinho PD Nisen 1995 Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells Nat Med 1 638 43 10.1038/nm0795-638
39. EH Postel SJ Berberich SJ Flint CA Ferrone 1993 Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis Science 261 478 80 10.1126/science.8392752
40. S Mitra I Boldogh T Izumi TK Hazra 2001 Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage Environ Mol Mutagen 38 180 90 10.1002/em.1070
41. SE Kane MM Gottesman 1990 The role of cathepsin L in malignant transformation Semin Cancer Biol 1 127 36
42. GA Taylor MJ Thompson WS Lai PJ Blackshear 1995 Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro J Biol Chem 270 13341 7 10.1074/jbc.270.22.13341
43. E Carballo WS Lai PJ Blackshear 1998 Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin Science 281 1001 5 10.1126/science.281.5379.1001
44. M Kitagawa I Saito T Kuwata 1997 Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes Leukemia 11 2049 54 10.1038/sj.leu.2400844
45. YH Huang JY Wu Y Zhang MX Wu 2002 Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes Oncogene 21 6819 28 10.1038/sj.onc.1205854
46. R Rajapaksa N Ginzton LS Rott PL Greenberg 1996 Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells Blood 88 4275 87
47. A Kaeferstein U Krug J Tiesmeier 2003 The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML Leukemia 17 343 9 10.1038/sj.leu.2402805
48. GM Fuhler AL Drayer E Vellenga 2003 Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia Blood 101 1172 80 10.1182/blood.V101.3.1172
49. C Letourneux G Rocher F Porteu 2006 B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK EMBO J 25 727 38 10.1038/sj.emboj.7600980
50. ML Kruse A Arlt A Sieke 2005 Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells J Biol Chem 280 24849 56 10.1074/jbc.M501571200
51. R Kumar W Lutz E Frank HJ Im 2004 Immediate early gene X-1 interacts with proteins that modulate apoptosis Biochem Biophys Res Commun 323 1293 8 10.1016/j.bbrc.2004.09.006
52. X Wang GP Studzinski 1997 Antiapoptotic action of 1, 25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c Exp Cell Res 235 210 7 10.1006/excr.1997.3667
53. JE Parker GJ Mufti 2000 Excessive apoptosis in low risk myelodysplastic syndromes (MDS) Leuk Lymphoma 40 1 24 10.3109/10428190009054877
54. MX Wu Z Ao KV Prasad R Wu SF Schlossman 1998 IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival Science 281 998 1001 10.1126/science.281.5379.998
55. A Czibere WC Prall LF Zerbini 2005 The nonsteroidal anti-inflammatory drug exisulind selectively induces apoptosis via JNK in secondary acute myeloid leukemia after myelodysplastic syndrome Cell Cycle 4 812 7
56. A Czibere WC Prall LF Zerbini 2006 Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS Br J Haematol 135 355 7 10.1111/j.1365-2141.2006.06298.x
57. A List M Beran J DiPersio 2003 Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes Leukemia 17 1499 507 10.1038/sj.leu.2403021
58. A Arlt J Minkenberg B Kocs 2004 The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells Leukemia 18 1646 55 10.1038/sj.leu.2403481
59. A Semlali J Oliva E Badia M Pons MJ Duchesne 2004 Immediate early gene X-1 (IEX-1), a hydroxytamoxifen regulated gene with increased stimulation in MCF-7 derived resistant breast cancer cells J Steroid Biochem Mol Biol 88 247 59 10.1016/j.jsbmb.2003.12.005
60. T Braun G Carvalho A Coquelle MC Vozenin P Lepelley F Hirsch JJ Kiladjian V Ribrag P Fenaux G Kroemer 2006 NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome Blood 107 1156 65 10.1182/blood-2005-05-1989
61. E Terpos E Verrou A Banti V Kaloutsi A Lazaridou K Zervas 2007 Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis Leuk Res 31 559 62 10.1016/j.leukres.2006.05.018